- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial2009 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial2009 | First Faculty of Medicine
- Indications of allogeneic and autologous haematopoietic cells transplantation, Recommendations of the Czech Society of Haematology and Czech Society of Oncology of the J. E. Purkyně Czech Medical Association2007 | First Faculty of Medicine
- Indications of allogeneic and autologous haematopoietic cells transplantations. Recommendations of the Czech Socienty of Haematology and Czech Society of Oncology of the J. E. Purkyně Czech Medical Association +12006 | Central Library of Charles University, Third Faculty of Medicine
- Indications of allogeneic and autologous haematopoietic cells transplantations. Recommendations of the Czech Socienty of Haematology and Czech Society of Oncology of the J. E. Purkyně Czech Medical Association2006 | Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Haematopoietic Cell Transplantation in Chronic Granulomatous Disease: a Study on 712 Children and Adults2020 | Second Faculty of Medicine
- Outcome of allogeneic haematopoietic cell transplantation in eosinophilic disorders: A retrospective study by the chronic malignancies working party of the EBMT2022 | Publication without faculty affiliation
- Prognostic factors to predict outcome of reduced intensity allogeneic haematopoietic cell transplantation for chronic lymphocytic leukemia2016 | Faculty of Medicine in Pilsen
- Indications for allogeneic and autologous haematopoietic cell transplantations in the Czech Republic in 2016: Recommendations of the Transplant Section of the Czech Society of Haematology and the Czech Society of Oncology of the J. E. Purkyně Medical Association2016 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial2009 | Faculty of Medicine in Hradec Králové
- Treatment of rare invasive mycoses (mucormycosis, cryptococcosis, fusariosis) in patients with leukaemia and following haematopoietic cell transplant (expert recommendations supported by CELL, ČHS JEP, ČOS JEP, SOS)2014 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT2024 | Publication without faculty affiliation
- Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study2021 | Faculty of Medicine in Hradec Králové
- Transplantation of haematopoietic cells2003 | First Faculty of Medicine
- TRENDS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION OVER THE PAST 21 YEARS - A SINGLE CENTRE ANALYSISPublication without faculty affiliation
- Role of ruxolitinib in the treatment of primary myelofibrosis2015 | Faculty of Medicine in Hradec Králové
- Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective2017 | Third Faculty of Medicine
- Skin explant model assay - A tool for detection of autoaggression in patients with rheumatoid arthritis1999 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial2023 | Publication without faculty affiliation